Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records.

Cancer should be considered in patients with raised inflammatory markers. However, inflammatory markers have a poor sensitivity for cancer and are therefore not useful as 'rule-out' test.